Sheryene N. Tejeda

Sheryene N. Tejeda (MD, PhD MHS MFS) is an American biomedical doctor and internationally published scientist. Her contributions to the understanding of endometriosis include developing the Tejeda Equation which explains how endometriosis develops.
Tejeda is the founder of Medicinal Technologies, a biomedical and biotechnology company. She also founded a nonprofit organization called Tejeda Foundation Inc.
Education
Tejeda has earned an MD and PhD in Biomedical Sciences from Einstein Medical School, including multiple Master's degrees in Psychology, Health Science, and Forensic Science.
Career
Tejeda began her career as a forensic therapist. She later started to work in clinical research for pharmaceutical companies and private research firms. In 2018 she established her own biomedical company, Medicinal Technologies.
Research and product development
The Endogen treatment protocol addresses endometriosis by targeting deviations in the GnRH gene, crucial for female reproductive health. Presigen IV regulates eye fluid balance to reduce intraocular pressure, benefiting patients with glaucoma. Endoil, originally part of Endogen, has also proven effective in treating joint pain, arthritis, and other inflammatory conditions.

Main Menu

See Also

Main Menu